“In a previous trial of VIP for ARDS (Acute Respiratory Distress Syndrome) caused by sepsis, seven of eight patients on mechanical ventilation showed substantial improvement and six ultimately left the hospital alive,” said Jonathan Javitt, MD... DelawareBusinessNow
Tuesday, June 9, 2020
Wilmington pharma company teams up with Swiss company on drug that could aid COVID-19 patients with respiratory distress
“In a previous trial of VIP for ARDS (Acute Respiratory Distress Syndrome) caused by sepsis, seven of eight patients on mechanical ventilation showed substantial improvement and six ultimately left the hospital alive,” said Jonathan Javitt, MD... DelawareBusinessNow
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment